Treatment for kidney injury in cirrhosis patients
Part of Digestive system, Kidney & urinary clinical trials.
This study tests a treatment for sudden kidney injury in people with liver cirrhosis. It may help if you are in the hospital for liver problems and have new kidney issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have confirmed liver cirrhosis.
- You are currently hospitalized for a sudden worsening of your liver condition or for evaluation.
- You cannot be on dialysis or have end-stage kidney disease.
- You cannot be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at acute kidney injury in patients who are very sick in the intensive care unit (ICU). It may help doctors better understand and manage kidney problems in these patients.
This study tests whether giving a common fluid (albumin) early can help protect the kidneys in people with advanced liver disease who have a sudden kidney injury. It aims to see if this simple treatment can improve recovery and prevent the need for dialysis.
This trial tests whether giving albumin (a blood protein) in a personalized dose works better than a standard fixed dose for people with cirrhosis and sepsis-related acute kidney injury. The goal is to find a safer and more effective way to protect kidney function.
This trial tests ways to protect the kidneys in intensive-care patients who have moderate or severe acute kidney injury. If you are on a ventilator or medications to support blood pressure, this study may offer extra kidney care to help prevent further damage.
This study looks at how liver cirrhosis affects the kidneys over a short period of time. Being in the study helps doctors understand kidney changes in people with cirrhosis who are in the hospital.
This study looks at people with acute (sudden) kidney injury, based on changes in a blood test called creatinine. By tracking these patterns during hospitalization, it may help improve how acute kidney injury is identified and managed.
Hear when a new AKI in Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.